The angiotensin II AT1-receptor antagonist candesartan reduces infarct size in pigs.

被引：0
|
作者：
Jalowy, A [1 ]
Schulz, R [1 ]
Post, H [1 ]
Dörge, H [1 ]
Weidenbach, R [1 ]
Behrends, M [1 ]
Heusch, G [1 ]
机构：
[1] Univ Hosp Essen, Dept Pathophysiol, Essen, Germany
来源：
FASEB JOURNAL | 1998年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
6446
引用
收藏
页码：A1114 / A1114
页数：1
相关论文
共 50 条
  • [21] Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer
    Kosugi, M
    Miyajima, A
    Kikuchi, E
    Horiguchi, Y
    Murai, M
    CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2888 - 2893
  • [22] Antitumor effect of angiotensin II type 1 receptor antagonist (candesartan) on mammary cancer in mouse.
    Muramatsu, M
    Okamoto, Y
    Takai, S
    Miyazaki, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 165P - 165P
  • [23] Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice
    Sonia Villapol
    Alexandra K Yaszemski
    Trevor T Logan
    Enrique Sánchez-Lemus
    Juan M Saavedra
    Aviva J Symes
    Neuropsychopharmacology, 2012, 37 : 2817 - 2829
  • [24] Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice
    Villapol, Sonia
    Yaszemski, Alexandra K.
    Logan, Trevor T.
    Sanchez-Lemus, Enrique
    Saavedra, Juan M.
    Symes, Aviva J.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (13) : 2817 - 2829
  • [25] The angiotensin II receptor antagonist candesartan is not effective in reducing portal hypertension in patients with cirrhosis
    Heim, Markus H.
    Jacob, Ludwig
    Beglinger, Christoph
    DIGESTION, 2007, 75 (2-3) : 122 - 123
  • [26] Pharmacological aspects of candesartan, an effective AT1-receptor blocker
    Unger, T
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2004, 6 (0H) : H11 - H16
  • [27] Involvement of angiotensin II in cardiovascular and renal injury:: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype
    Kim, S
    Iwao, H
    JOURNAL OF HYPERTENSION, 1997, 15 : S3 - S7
  • [28] Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination -: An experimental study in rats
    Engelhorn, Tobias
    Doerfler, Arnd
    Heusch, Gerd
    Schulz, Rainer
    NEUROSCIENCE LETTERS, 2006, 406 (1-2) : 92 - 96
  • [29] Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans
    Yamashiro, Wakaba
    Maeda, Kazuya
    Hirouchi, Masakazu
    Adachi, Yasuhisa
    Hu, Zhuohan
    Sugiyama, Yuichi
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (07) : 1247 - 1254
  • [30] Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptors
    Nishimura, Y
    Ito, T
    Hoe, KL
    Saavedra, JM
    BRAIN RESEARCH, 2000, 871 (01) : 29 - 38
12345